Bank Of New York Mellon Corp 2seventy Bio, Inc. Transaction History
Bank Of New York Mellon Corp
- $528 Trillion
- Q2 2024
A detailed history of Bank Of New York Mellon Corp transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 196,959 shares of TSVT stock, worth $866,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
196,959
Previous 186,882
5.39%
Holding current value
$866,619
Previous $1 Billion
24.16%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TSVT
# of Institutions
122Shares Held
48.2MCall Options Held
211KPut Options Held
9.7K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$26.2 Million1.78% of portfolio
-
Goldman Sachs Group Inc New York, NY4.14MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$16 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$14.4 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $167M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...